Titan Medical (TSX:TMD) CEO David McNally told shareholders today that the company must raise $85 million to finish developing its Sport robot-assisted surgery device and file for FDA clearance
Scurvy: reemergence of nutritional deficiencies
Other peptides, like GHRPs and AOD-9604, show promise but are often used off-label or experimentally
By combining diagnostics, medication when appropriate, and proven behavior change, we help your body work better from the inside out. Nooms Chief Medical Officer FAQ Read more about weight-loss medications Our clinical team offers a wide array of medications to give the best treatment to those who qualify.
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
GLP-1 medications are not approved and generally not effective for type 1 diabetes because the autoimmune destruction of beta cells means there are no functioning insulin-producing cells for GLP-1 to stimulate